The difference in NCDs metabolic risk factors’ prevalence between the two surveys. by Mehran Asadi-Aliabadi (8383110)

Subjects:

CONSORT flow diagram. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Demographic and economic characteristics of participants (frequencies and percentages). by Mehran Asadi-Aliabadi (8383110)

Subjects:

Districts of intervention and no intervention in IRPONT study. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Stigma scores as measured with the SDS across assessments and vignettes. by Kristen S. Regenauer (13842386)

Subjects:

Clinical competency scores as measured with the ENACT across assessments. by Kristen S. Regenauer (13842386)

Subjects:

Outcome variable descriptive statistics. by Kristen S. Regenauer (13842386)

Subjects:

Demographic & job characteristics. by Kristen S. Regenauer (13842386)

Subjects:

Training feedback. by Kristen S. Regenauer (13842386)

Subjects:

Study flow. by Kristen S. Regenauer (13842386)

Subjects:

Scheme of g-λ model with larger values λ. by Zhanfeng Fan (20390992)

“…The findings suggest that when λ is respectively equal to 4.19, 8.57, 10, and 12.15, the peak particle velocity (PPV) of the transmitted waves is significantly close to the incident wave amplitude. Furthermore, when λ is fixed, the energy transmission coefficient increases with the incident wave amplitude but decreases with the incident wave frequency. …”

Significant main effect of housing type. by Grace Hecker (18813445)

Significant interactions and main effects of day. by Grace Hecker (18813445)

Mean CCECAI over time between the placebo and FMT group. by Allison J. Collier (13977858)

Subjects:

LefSe of bacterial taxa and their association with the one-week post FMT samples, demonstrating taxa with an LDA >2. by Allison J. Collier (13977858)

Subjects:

Fig 3 - by Allison J. Collier (13977858)

Subjects:

Relative abundances of the main bacterial families enriched between the pre and one-week post FMT samples. by Allison J. Collier (13977858)

Subjects:

The CCECAI between treatment groups at baseline, day 7 and day 30. by Allison J. Collier (13977858)

Subjects:

Patient data throughout the study. by Allison J. Collier (13977858)

Subjects:

Characteristics of dogs in the FMT and placebo groups at baseline. by Allison J. Collier (13977858)

Subjects: